Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only, Manufactured for: ...
FDA Recall #D-0871-2023 — Class III — June 12, 2023
Product Description
Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only, Manufactured for: Amring Pharmaceuticals Inc. Berwyn, PA 19312, NDC 69918-301-30
Reason for Recall
Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.
Recalling Firm
Amring Pharmaceuticals Inc — Berwyn, PA
Classification
Class III — Not likely to cause adverse health consequences.
Product Type
Drugs
Product Quantity
48,989 bottles
Distribution
Nationwide in the USA.
Code Information
Lots: X220317A and X220318A, exp. date 09/25
Status
Terminated
Voluntary / Mandated
Voluntary: Firm initiated
What Should You Do?
Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.